by Dr John Briffa
for the Cholesterol Truth


This week’s New England Journal of Medicine (NEJM) contains an interesting editorial from Dr. Eric Topol [1]. The editorial focuses on the drug nesiritide (Natrecor) used to treat heart failure (where heart function is weak and can cause symptoms such as fatigue and breathlessness, and ultimately lead to death). The drug was licensed in the US by the Food and Drug Administration (FDA) in 2001. Since then, about $1 billion has been spent on this drug. The only problem is, it doesn’t work very well.

That may sound like a lot of money to you or I, but it’s actually a drop in the bucket compared to the profits made through the sales of this drug. Unpalatable though this idea is, even once legal cases are settled, it sometimes still pays drug companies to aggressively market drugs that have no proven benefit.

Read the Full Article Here:


The Great Cholesterol Con
The Truth About What Really Causes Heart Disease and How to Avoid It
by Dr. Malcolm Kendrick

Retail: $16.95
Now: $13.99
More Info